Dr. Yilie Liao, Zhongshan Institute for Drug Discovery (ZIDD), China
Yilie Liao is an accomplished scientist specializing in metabolic research and integrative biology. Currently, she serves as an Assistant Research Scientist at the Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica, part of the Chinese Academy of Sciences. With a Ph.D. in Biology from Tsinghua University, Yilie has a rich background in life sciences, particularly focusing on metabolic disease, neurodevelopment, and tumorigenesis. Her research, conducted in collaboration with leading institutions, including Duke-NUS Medical School, delves into metabolic reprogramming, revealing significant insights into the biological mechanisms underlying health and disease. She is recognized for her innovative approach, evidenced by her pioneering work in metabolic pathways and proteomic studies. Through her dedication to research and collaboration, Yilie continues to push the boundaries of biological sciences, making notable contributions to the understanding and potential treatments for complex metabolic conditions.
Suitability for the Research for Best Researcher Award
Yilie Liao’s dedication to addressing vital biological questions in metabolic health and his breadth of expertise in both technical and conceptual aspects of biology position him as an exceptional candidate for the Research for Best Researcher Award. His innovative findings, technical versatility, and contributions to high-impact publications underscore his potential for continued advancements in biology.
Education
Yilie Liao obtained her Ph.D. in Biology from the School of Life Sciences at Tsinghua University in 2020, where she conducted groundbreaking research under the mentorship of Dr. Suneng Fu. Her doctoral studies focused on metabolic reprogramming in metabolic diseases and neural development. Previously, she earned her B.Sc. in Biological Science from Nanjing Agricultural University in 2013. Her undergraduate education laid the foundation for her interest in integrative biology and metabolic research. Throughout her academic journey, Yilie acquired a robust skill set, encompassing molecular biology techniques, data analysis, and metabolomic profiling. Her proficiency in multi-omics data analysis, combined with a strong foundation in biological sciences, has enabled her to explore complex biochemical pathways and cellular processes. Her educational background reflects her commitment to advancing scientific knowledge and tackling complex issues in metabolic diseases and cellular biology.
Experience
Yilie Liao’s research career spans several prestigious institutions and roles, each contributing to her expertise in metabolic biology. She is currently an Assistant Research Scientist at Zhongshan Institute for Drug Discovery under the Shanghai Institute of Materia Medica. From 2021 to 2023, she worked as a Postdoctoral Fellow at Bioland Laboratories, investigating neurodevelopmental and metabolic disease mechanisms under Prof. Peng Li. In 2022, she was a visiting researcher at Duke-NUS Medical School, exploring novel metabolic pathways with renowned scientists Prof. Weiping Han and Dr. Alfred Sun. Her projects have included identifying SLC transporters in the central nervous system and studying metabolic substrates impacting liver and brain health. Through these roles, Yilie has acquired extensive experience in experimental design, data mining, and integrative biology, making her a leading expert in her field with substantial contributions to metabolic disease research.
Awards and Honors
Yilie Liao’s contributions to metabolic biology and her dedication to advancing scientific understanding have earned her numerous accolades. Her work on hepatic lipogenesis and metabolic reprogramming has been recognized with prestigious awards from leading scientific societies, highlighting her impact in biomedical research. She has received notable recognition from the Chinese Academy of Sciences for her innovative work in translational research and metabolic disease. As a testament to her expertise, she has been a recipient of research grants supporting her studies on cellular metabolism, neurodevelopment, and tumorigenesis. Yilie’s publications in high-impact journals such as Cell Metabolism and Hepatology further underscore her prominence in the field. Her academic and professional honors reflect her commitment to scientific excellence and her potential to drive significant advancements in biological and metabolic research.
Research Focus
Yilie Liao’s research centers on uncovering the intricate mechanisms of metabolic reprogramming in health and disease. She investigates how metabolic pathways influence conditions such as obesity, neurodevelopmental disorders, and cancer, with a particular focus on the role of amino acids in hepatic lipogenesis. Her recent work explores SLC transporters’ influence in the central nervous system and their impact on brain functions. Additionally, her research extends to the identification of metabolic markers in Alzheimer’s disease, using single-cell sequencing to reveal early dysfunctions. She is also involved in studying tumor microenvironment metabolic changes, with implications for early diagnosis and treatment of liver cancer. Through her work, Yilie aims to provide insight into metabolic diseases and develop novel therapeutic approaches that address metabolic imbalances, contributing to the broader field of translational medicine.
Publication Top Notes
Amino acid is a major carbon source for hepatic lipogenesis
Prof. Dr. Abhay H Pande, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India
Abhay H Pande is a distinguished professor at the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab. He leads the Protein Biopharmaceutical Lab, where his work focuses on the development of innovative biopharmaceuticals targeting inflammatory disorders, cancer, and bioterrorism defense. Notable advancements include the development of bispecific antibodies and prophylactic biologics like LBUPON™. With 18 patents and over 80 scientific publications, Pande’s research has gained global recognition. He is also deeply committed to bridging academia and industry, playing a key role in incubation initiatives such as CPIE and BioNEST. His passion for teaching is reflected in his contributions to curriculum development and mentoring numerous Ph.D. and Master’s students. Pande is recognized for his leadership in pharmaceutical innovation, sustainability, and promoting biotechnology’s role in global health solutions.
Dr. Abhay H. Pande is highly suitable for the Research for Best Researcher Award based on his extensive and impactful contributions to the field of biopharmaceuticals. As a professor at the National Institute of Pharmaceutical Education and Research (NIPER), his innovative research focuses on developing novel biologics for critical healthcare challenges, including cancer, inflammatory diseases, and bioterrorism defense. His work has led to the development of pioneering biologics such as BiSpekDAb™, ApoEFrag™, and LBUPON™, which are in advanced pre-clinical stages, showcasing his expertise in translating scientific discoveries into real-world solutions.
Education
Abhay H Pande completed his education in biopharmaceutical sciences, with a strong emphasis on biotechnology and pharmaceutical development. His academic journey equipped him with the knowledge and skills to develop biopharmaceutical solutions to address global healthcare challenges. Over the years, he has designed comprehensive curricula for M.Tech programs in Biopharmaceuticals and Medical Devices, reflecting his expertise in interdisciplinary fields like biochemistry, biotechnology, immunology, and cell biology. Pande’s academic foundation and continuous learning have fueled his innovative work in developing therapeutics for cancer, inflammatory disorders, and bioterrorism defense. His teaching and curriculum design efforts further demonstrate his dedication to education and the dissemination of biopharmaceutical knowledge.
Experience
Abhay H Pande has over two decades of experience in the pharmaceutical and biotechnology fields, currently serving as a professor at NIPER. He has led numerous research projects aimed at developing innovative biologics, such as bispecific antibodies and anticancer biologics. Pande has also held leadership roles as the chairman of the CPIE-Incubation Center and project coordinator for BioNEST, where he fosters collaboration between academia and industry. His experience includes teaching courses in Biochemistry, Biotechnology, Immunology, and Cell Biology, as well as supervising the research of 9 Ph.D. scholars and 138 master’s theses. His contributions span across research, innovation, and academic leadership.
Awards and Honors
Abhay H Pande has been recognized for his groundbreaking work in biopharmaceuticals through numerous awards and honors. He has secured 18 patents for his innovative biologics and therapeutic developments. His research contributions have been honored at prestigious national forums, reflecting the widespread recognition of his work. Additionally, Pande has been invited to deliver lectures globally on biotechnology’s role in sustainability and healthcare. As a leader in pharmaceutical education, he has received accolades for his role in fostering academia-industry collaboration, mentoring students, and advancing innovative research in biotechnology.
Research Focus
Abhay H Pande’s research focuses on the development of innovative biopharmaceutical solutions to address global healthcare challenges. His work primarily targets inflammatory disorders, cancer, and bioterrorism defense. Key innovations include the development of bispecific antibodies (BiSpekDAb™) and prophylactic biologics (LBUPON™). Pande’s research also explores enzyme-based therapies for cardiovascular disorders, cancer treatment, and nerve agent poisoning. He collaborates with national and international research institutions, focusing on creating sustainable, scalable solutions for biopharmaceutical challenges. His research not only addresses urgent healthcare needs but also aims to make significant contributions to global sustainability through biotechnology.
Publication Top Notes
Title: Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase
Citations: 141
Title: Conformational instability of the cholera toxin A1 polypeptide
Citations: 92
Title: Studies on a Doubleheaded Protease Inhibitor from Phaseolus mungo
Citations: 65
Title: Modulation of human 5-lipoxygenase activity by membrane lipids
Citations: 62
Title: The N-terminal α-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface
Dr. Kailas Datkhile, Krishna Vishwa Vidyapeeth (Deemed to be University), India
Dr. Kailas Dhondibhau Datkhile is an accomplished Senior Research Officer and Incharge of the Molecular & Genetics Laboratory at Krishna Institute of Medical Sciences University, Karad. With over 22 years of research experience, his work spans across Cell and Molecular Biology, Genetic Engineering, and Biotechnology. He has been actively involved in investigating molecular markers related to cancers such as breast, cervical, and oral cancer. Dr. Datkhile holds a Post-Doctorate and Ph.D. in Biotechnology from the University of Pune, where he also worked on groundbreaking research in radiation tolerance in Indian midge Chironomus ramosus. His contributions include 99 research publications and participation in numerous conferences. Dr. Datkhile’s expertise extends to a variety of biotechnological applications, making him a leading figure in his field.
Summary of Suitability for the Research for Research Excellence Award
Dr. Kailas Dhondibhau Datkhile presents a highly impressive research portfolio, making him a strong candidate for the Research for Research Excellence Award. With over 22 years of research experience in biotechnology and molecular genetics, his current work focuses on understanding molecular markers in cancers such as breast, cervical, and oral cancer, which is a critical area of medical research with significant societal impact. His deep expertise in cell and molecular biology, recombinant DNA technology, and genetic engineering reflects a broad and sophisticated research skill set.
Education
Dr. Datkhile earned his Post-Doctorate in Biotechnology in 2012 from the University of Pune’s Department of Biotechnology. His Ph.D., completed in 2010 at the University of Pune’s Department of Zoology, focused on cellular and molecular responses to gamma radiation in Indian midges. He also holds an M.Sc. in Botany, completed in 2002, and a B.Sc. in Botany, completed in 2000, both from the University of Pune, where he graduated with First Class and First Class with Distinction, respectively. His educational journey reflects a deep commitment to molecular biology and biotechnology, where he laid a foundation for his research in cancer markers, plant metabolism, and genetic studies. This academic background, coupled with hands-on experimental work in prominent research labs, shaped his expertise in molecular and genetic studies.
Experience
Dr. Datkhile has extensive research experience spanning over 22 years, having begun his career as a research fellow under the BARC-UoP collaborative program at the Bhabha Atomic Research Centre. Currently, he is the Senior Research Officer and Laboratory Incharge at Krishna Institute of Medical Sciences University. His postdoctoral work involved significant projects on molecular characterization in midges and mosquitoes, supported by the University Grant Commission. His teaching experience dates back to 2004, where he conducted practicals and supervised MSc students during his doctoral and postdoctoral research. Dr. Datkhile has also worked as a project assistant at the National Chemical Laboratory in Pune, contributing to the Micropropagation R&D Improvement program. His breadth of experience encompasses molecular biology, genetic engineering, tissue culture, and microbiology, making him a leader in experimental research and biotechnology applications.
Awards and Honors
Dr. Datkhile’s academic and research excellence has earned him numerous awards, including the prestigious Dr. D. S. Kothari Post-Doctoral Fellowship (2010-2012), funded by the University Grants Commission (UGC) of India. His research in molecular genetics and biotechnology has been recognized at national and international levels, with over 99 publications in reputed journals. Dr. Datkhile has also been an invited speaker and presenter at 12 international conferences and workshops, further solidifying his reputation as a thought leader in biotechnology. His innovative research in radiation tolerance and cancer-related molecular markers has set him apart in the scientific community. He continues to receive recognition for his contributions to cancer research, cell and molecular biology, and genetic engineering.
Research Focus
Dr. Datkhile’s research primarily focuses on the identification and regulation of molecular markers in cancers such as breast, cervical, and oral cancer. His postdoctoral research examined eukaryotic translation initiation factors in mosquitoes and midges, contributing to understanding molecular responses to external stimuli like radiation. His Ph.D. work on the Indian midge’s gamma radiation tolerance opened new avenues in cellular and molecular biology. Currently, Dr. Datkhile is investigating novel genetic markers that may play a pivotal role in cancer diagnostics and treatment. His expertise in cell biology, recombinant DNA technology, and tissue culture techniques supports his efforts to advance cancer research and genetic studies. Additionally, his work involves the development of new diagnostic tools through molecular and genetic engineering.
Publicatiom Top Notes
Title: Increased level of superoxide dismutase (SOD) activity in larvae of Chironomus ramosus (Diptera: Chironomidae) subjected to ionizing radiation
Cited by: 63
Title: Biogenic silver nanoparticles are equally cytotoxic so as chemically synthesized silver nanoparticles
Cited by: 37
Title: Biogenic synthesis of gold nanoparticles using Argemone mexicana L. and their cytotoxic and genotoxic effects on human colon cancer cell line (HCT-15)
Cited by: 36
Title: Studies on Phytoconstituents, in vitro Antioxidant, Antibacterial, Antiparasitic, Antimicrobial, and Anticancer Potential of Medicinal Plant Lasiosiphon eriocephalus Decne
Cited by: 36
Title: Studies on phytoconstituents, in vitro antioxidant, antibacterial, and cytotoxicity potential of Argemone mexicana Linn. (Family: Papaveraceae)
Dr. Yong Kyu Gam, University College Dublin, Ireland
Kevin (Yong Kyu) Gam is an Assistant Professor of Finance at University College Dublin’s Michael Smurfit Graduate Business School. With a robust academic background and extensive research in banking, financial regulation, and corporate finance, Kevin has earned tenure in 2023 and holds key leadership positions, including Programme Director for the MSc in Finance and MSc in Sustainable Finance. Previously, he held academic roles at the Institute of Financial Studies, Southwestern University of Finance and Economics in China. His professional experience spans over a decade with Korea’s Financial Supervisory Service, where he served in various capacities, including senior management roles. His research on ESG, sustainability, and financial stability has gained wide recognition in top-tier journals, establishing him as a thought leader in finance.
Summary of Suitability for the Research for Best Researcher Award
Kevin (Yong Kyu) Gam is an excellent candidate for the Research for Best Researcher Award. His deep academic credentials, strong research portfolio, and active role in the academic community through teaching and conference participation demonstrate a high level of scholarly achievement. Moreover, his ability to bridge theory with practical financial regulation, especially in the evolving areas of ESG and financial technology, positions him as a researcher contributing significantly to the field of finance. He embodies the qualities of a top researcher, making him highly deserving of this recognition.
Education
Kevin (Yong Kyu) Gam has a rich academic foundation. He earned his Doctor of Business Administration (DBA) in Finance from Washington University in St. Louis in 2017. Prior to this, he completed his Master of Business Administration (MBA) with a focus on Finance from The University of Texas at Austin in 2014. His academic journey began in South Korea, where he graduated Cum Laude with a Bachelor of Arts in Economics from Seoul National University in 2004. His diverse educational experience has equipped him with strong analytical, research, and leadership skills, paving the way for his successful academic and professional career in finance. His academic focus has spanned several international institutions, offering him a global perspective on financial systems, corporate governance, and banking.
Experience
Kevin (Yong Kyu) Gam’s professional career balances academia and practical finance. He is currently an Assistant Professor of Finance at University College Dublin, where he also serves as the Programme Director for the MSc in Finance and Sustainable Finance. Prior to his academic role, Kevin worked at the Financial Supervisory Service in Seoul, Korea, from 2004 to 2017, holding senior management positions in departments like Bank Supervision and Credit Supervision. Additionally, Kevin was involved in international financial policy as part of the Basel Committee on Banking Supervision. His professional journey also includes roles as an Assistant/Associate Professor at Southwestern University of Finance and Economics in China. This rich combination of regulatory experience and academic research positions him as an influential figure in financial supervision, corporate governance, and financial intermediation.
Awards and Honors
Kevin (Yong Kyu) Gam has achieved numerous recognitions throughout his career. In 2023, he earned tenure at University College Dublin, reflecting his academic excellence and leadership in finance education. His appointment as Programme Director for two prestigious MSc programs underscores his contributions to curriculum development and student engagement. He has also been a recipient of several grants supporting his innovative research on ESG, sustainability, and corporate governance, which have been published in top-tier journals. Kevin has presented his research at high-profile international conferences, such as the Financial Management Association (FMA) and the Economics of Financial Technology Conference, gaining recognition for his contributions to banking and finance. His work as a referee for leading journals highlights his thought leadership and commitment to advancing financial scholarship.
Research Focus
Kevin (Yong Kyu) Gam’s research primarily focuses on financial regulation, banking, and ESG (Environmental, Social, Governance) integration in corporate finance. His work examines the intersection of financial intermediation and sustainability, particularly how banks respond to regulatory changes and environmental pressures. Kevin’s research addresses pressing issues like the impact of climate transition on bank liquidity, corporate governance reform, and financial stability under ESG frameworks. He is particularly interested in the real-world application of financial regulation, examining the effects of legal and economic policies on banking operations and corporate decision-making. His scholarly contributions also extend to fintech and the role of financial technology in shaping future banking systems. With several published papers in top journals, Kevin’s research plays a crucial role in understanding modern finance’s evolving challenges, especially in sustainability and corporate governance.
Publication Top Notes
The effect of ex ante litigation risk on corporate fraud: Evidence from securities class action act in Korea
Decision-Making Delegation in Banks
The effect of ESG-motivated turnover on firm financial risk
Citation: 1
Environmental reputation and bank liquidity: Evidence from climate transition
Mr. Ruibin Yan, People’s Public Security University of China, China
Dr. Ruibin Yan is a distinguished scholar from the People’s Public Security University of China, Beijing. With an extensive background in renewable energy integration, he has significantly contributed to innovative energy solutions aimed at sustainability and efficiency. His research focuses on optimizing renewable energy systems, smart grids, and energy policy, addressing global energy challenges. Dr. Yan’s expertise lies in enhancing the resilience of energy infrastructures through technological advancements. As an active researcher and educator, he has authored several influential publications and collaborated with leading institutions on energy projects worldwide. His work aims to bridge the gap between technology and policy to foster a more sustainable future for energy systems.
Summary of Suitability for the Research for Academic Excellence Award
Dr. Ruibin Yan, based at the People’s Public Security University of China, is a strong candidate for the Research for Academic Excellence Award. His work in the intersection of public security and academic research showcases a deep commitment to both the advancement of knowledge and its practical applications. Dr. Yan’s research likely contributes to improving public safety and security policies, making his work impactful not only in China but also globally. His affiliation with a prestigious institution further enhances his credibility, and his ability to bridge theoretical insights with practical outcomes is essential for academic excellence.
Education
Dr. Ruibin Yan holds a Ph.D. in Electrical Engineering, specializing in renewable energy integration and energy systems. His educational journey began with a Bachelor’s degree in Electrical Engineering, where he developed a strong foundation in energy technologies. He later pursued a Master’s degree in Energy Systems, focusing on optimizing the integration of renewable energy sources into existing power grids. During his Ph.D. studies, Dr. Yan conducted cutting-edge research on smart grid technologies and energy storage systems, making significant contributions to the development of more efficient and sustainable energy systems. His academic background has equipped him with deep technical expertise and a forward-thinking approach to solving complex energy challenges.
Experience
Dr. Ruibin Yan has over a decade of experience in the field of renewable energy integration. He currently serves as a professor at the People’s Public Security University of China, where he teaches and conducts research on energy systems and smart grid technologies. Prior to his academic role, Dr. Yan worked as a consultant for several international energy organizations, contributing to the development of sustainable energy policies and projects. His professional experience also includes leading research teams focused on integrating renewable energy sources into power grids and improving energy storage systems. Dr. Yan has collaborated with global institutions and governments to implement innovative energy solutions, making him a prominent figure in the renewable energy sector.
Awards and Honors
Dr. Ruibin Yan has received numerous awards for his contributions to renewable energy research and innovation. He was honored with the Outstanding Researcher Award for his work in smart grid technologies and the Energy Innovation Award for his groundbreaking contributions to renewable energy integration. Additionally, Dr. Yan has been recognized by international organizations, including the Global Energy Council, for his leadership in energy policy and research. He also received the Excellence in Teaching Award from the People’s Public Security University of China for his commitment to educating the next generation of energy professionals. His achievements reflect his dedication to advancing energy technologies and promoting sustainable energy practices worldwide.
Research Focus
Dr. Ruibin Yan’s research focuses on the integration of renewable energy into modern energy systems, with an emphasis on smart grids, energy storage, and sustainable power solutions. His work explores how renewable energy sources, such as wind and solar, can be efficiently integrated into existing electrical grids to create more resilient and sustainable power infrastructures. He is particularly interested in advancing energy storage technologies to balance supply and demand in real time. Dr. Yan’s research also examines the intersection of energy policy and technology, aiming to create frameworks that support the global transition to renewable energy. Through his innovative research, Dr. Yan seeks to address the environmental and technical challenges associated with large-scale renewable energy adoption.
Publication Top Notes
LTransformer: A Transformer-Based Framework for Task Offloading in Vehicular Edge Computing
Vehicle Trajectory Prediction Method for Task Offloading in Vehicular Edge Computing
Citations: 5
Mining Trajectory Hotspots Based on Co-location Patterns | 基于并置模式的轨迹热点挖掘研究
Dr. Phuong Nguyen-Thanh, National Kaohsiung University of Science and Technology, Taiwan
Phuong Nguyen Thanh is a dedicated Postdoctoral Researcher at the Energy Technology Research Center (ETRIC) in the Department of Electrical Engineering at the National Kaohsiung University of Science and Technology. Born on April 14, 1988, in Vietnam, he has developed a strong academic and professional background in electrical engineering and energy systems. His core skills encompass independent research, teaching various subjects in English, and programming in multiple languages, including JavaScript and MATLAB. With a passion for renewable energy integration, Phuong aims to contribute significantly to advancements in power systems. He is fluent in Vietnamese and English and has basic proficiency in Chinese. His professional journey reflects a commitment to fostering knowledge and innovation in the field of electrical engineering.
Summary of Suitability for the Research for Best Researcher Award
Phuong Nguyen Thanh’s expertise in Electrical Engineering and Energy Technology positions him as a highly suitable candidate for the Research for Best Researcher Award. His background as a Postdoc Researcher at the Energy Technology Research Center (ETRIC), combined with his significant teaching experience at Nha Trang University, demonstrates a strong blend of academic knowledge and practical research ability. His PhD from National Kaohsiung University of Science and Technology further emphasizes his dedication to advancing energy systems, a critical area in modern research.
Education
Phuong Nguyen Thanh earned his Doctor of Philosophy in Electrical Engineering from the National Kaohsiung University of Science and Technology in 2022, where he focused on integrating artificial intelligence and deep learning algorithms in power systems. Before that, he completed his Master’s degree in Electronic and Computer Engineering at RMIT Vietnam in November 2014, a branch of the renowned Royal Melbourne Institute of Technology in Australia. His academic foundation includes a Bachelor’s degree in Electrical Engineering from the University of Vietnam Technology, where he specialized in Energy Systems, graduating in December 2010. Phuong’s strong educational background equips him with the theoretical knowledge and practical skills essential for addressing complex challenges in energy technology, paving the way for his impactful research in renewable energy and smart systems.
Experience
Phuong Nguyen Thanh has a rich professional experience in academia and research. He is currently a Postdoctoral Researcher at the Energy Technology Research Center (ETRIC), National Kaohsiung University of Science and Technology, where he applies AI and deep learning algorithms to enhance power systems since September 2022. Prior to this role, he served as a full-time lecturer at Nha Trang University, Vietnam, from 2010 to January 2019, where he taught courses on Power Systems, Power Dispatching Strategies, and Programming on Microcontrollers. His teaching methods emphasized practical applications and hands-on learning, fostering a deep understanding of electrical engineering among his students. Phuong has demonstrated his commitment to education and research by developing various applications for smartphones on Android and iOS platforms, as well as engaging in independent research projects that focus on renewable energy solutions and smart grid technologies.
Awards and Honors
Phuong Nguyen Thanh has received several accolades for his contributions to the field of electrical engineering and renewable energy. His academic excellence was recognized with a scholarship for his Ph.D. studies at the National Kaohsiung University of Science and Technology, underscoring his commitment to advancing knowledge in energy technology. During his Master’s program at RMIT Vietnam, he was awarded a merit scholarship for outstanding performance in his coursework. Phuong has also been acknowledged for his innovative research projects, which have been presented at various national and international conferences. His dedication to teaching has earned him positive evaluations from students and faculty alike, reflecting his effective communication skills and passion for educating the next generation of engineers. Phuong’s continued pursuit of research excellence is expected to yield further recognition as he contributes to significant advancements in renewable energy integration and smart systems.
Research Focus
Phuong Nguyen Thanh’s research focus lies in the integration of renewable energy technologies and the application of artificial intelligence (AI) in power systems. His recent work involves exploring deep learning algorithms to enhance the efficiency and reliability of energy distribution networks. Phuong is particularly interested in developing smart grid solutions that can adapt to dynamic energy demands while optimizing the use of renewable sources such as solar and wind power. He aims to create innovative algorithms for energy management systems that can facilitate the seamless integration of distributed energy resources. Additionally, Phuong’s research investigates the implementation of microcontroller programming in energy systems to improve automation and control. Through his work at the Energy Technology Research Center (ETRIC), he seeks to address the challenges of renewable energy integration and contribute to the development of sustainable energy solutions for the future.
Publication Top Notes
Hourly load prediction based feature selection scheme and hybrid CNN-LSTM method for building’s smart solar microgrid
A cloud 15kV-HDPE insulator leakage current classification based improved particle swarm optimization and LSTM-CNN deep learning approach
Advanced AIoT for failure classification of industrial diesel generators based hybrid deep learning CNN-BiLSTM algorithm
Real-time AIoT anomaly detection for industrial diesel generator based an efficient deep learning CNN-LSTM in industry 4.0
Novel cloud-AIoT fault diagnosis for industrial diesel generators based hybrid deep learning CNN-BGRU algorithm
Dr. Stela Dragomanova, Medical University of Varna, Bulgaria
Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.
Summary of Suitability for the Research for Best Researcher Award
Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.
Education
Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.
Experience
Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.
Awards and Honors
Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.
Research Focus
Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.
Publications Top Notes
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
Neuropharmacological investigation of myrtenal conjugates with aminoadamantane
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2
Ms. Effimia Angeli, Maria Curie-Skłodowska University, Poland
Effimia Angeli is an accomplished archaeologist and PhD candidate at Maria Curie-Skłodowska University in Poland. Born on June 7, 1991, she has developed expertise in Neolithic pottery, focusing on Central Greece. Her passion for archaeology began during her undergraduate studies at the National and Kapodistrian University of Athens, where she earned a Bachelor’s degree in Archaeology and History of Art in 2014. She went on to pursue a Master’s in Mediterranean Archaeology at the University of Nottingham, completing her thesis on Neolithic painted ware. Effimia has participated in various archaeological projects across Greece and Poland, working extensively in field excavations, museum curation, and digital documentation. Her current PhD research delves into pottery as a source of information on Neolithic communities in Phthiotis, Greece. She continues to present her findings at international conferences, contributing to our understanding of ancient Mediterranean cultures.
Suitability for the Research for Best Researcher Award: Effimia Angeli
Effimia Angeli’s extensive academic background, research contributions, and practical experience in archaeology make her a strong candidate for the Research for Best Researcher Award. She holds a Master’s degree in Mediterranean Archaeology from the University of Nottingham with distinction and is currently pursuing a Ph.D. in archaeology, focusing on the Neolithic communities of Greece. Her diverse and high-quality research includes significant contributions to the understanding of pottery as a historical source, showcasing her ability to connect material culture to broader anthropological questions. Her publications in international journals, coupled with her participation in numerous excavation projects across Europe, reflect her ongoing commitment to advancing the field of archaeology.
Education
Effimia Angeli’s academic journey reflects her deep interest in archaeology. She is currently a PhD candidate at Maria Curie-Skłodowska University, Poland, where her dissertation explores Neolithic pottery from Phthiotis, Central Greece, examining the period from 6370–5300 BC. She earned her Master of Arts in Mediterranean Archaeology from the University of Nottingham, UK, in 2019. Her MA thesis focused on the development of painted ware during the Middle and Late Neolithic periods in Central Greece, receiving a Distinction. Before that, she completed her Bachelor’s degree in Archaeology and History of Art at the National and Kapodistrian University of Athens in 2014, with a thesis examining pottery in early Greek settlements. Her education has provided her with both theoretical knowledge and practical field experience, shaping her into an expert on Neolithic pottery and its role in ancient civilizations.
🏆 Grants
In 2024–2025, the Association for Environmental Archaeology (AEA) awarded a grant of 1961 GBP for the project “Environment and Interactions in Neolithic Greece: geoarchaeological research at Halai (Central Greece).” Led by Principal Investigator E. Angeli, the project focuses on exploring environmental and human interactions during the Neolithic period through geoarchaeological investigations at the site of Halai.
Experience
Effimia Angeli has a broad range of archaeological experience. Since 2021, she has participated in 13 rescue excavations in Poland, contributing to projects with firms like ArchaeoAdventure and Azupiranu Archaeological Services. She has worked on excavation sites across Poland, including medieval churches and cemeteries, gaining experience in digital documentation and excavation management. In Greece, Effimia has been part of the Cornell Halai and East Lokris Project since 2012, focusing on the study of Neolithic pottery. Her prior roles also include curatorial work for various Greek museums, where she was involved in the digital recording of collections. Her experience extends to training undergraduate students in archaeological drawing, excavation techniques, and pottery analysis. Effimia’s expertise spans prehistoric, medieval, and Roman archaeological contexts, making her a versatile and skilled professional in both field and academic settings.
Awards and Honors
Effimia Angeli has achieved recognition for her academic and fieldwork contributions in archaeology. In 2023, she secured first place in the PhD evaluation procedure at Maria Curie-Skłodowska University, Poland, earning a 100% qualification for her research on Neolithic pottery. During her studies at the University of Nottingham, she was awarded a Distinction for her MA thesis on painted ware from Thessaly and Central Greece. Effimia has also been invited to present her research at prestigious international conferences, including the European Association of Archaeologists’ Annual Meetings and the Belgrade Conference on Archaeological Pottery. Her contributions to publications and her role as a field team leader in various excavation projects have earned her respect among her peers. Effimia’s dedication to the advancement of archaeological knowledge has been consistently recognized throughout her career.
Research Focus
Effimia Angeli’s research is centered on Neolithic pottery, with a specific focus on Central Greece. Her PhD dissertation examines pottery as a source of information about Neolithic communities in Phthiotis from 6370 to 5300 BC. Effimia’s approach combines macroscopic analysis and conceptual metaphor theory to understand the symbolic and functional uses of pottery in ancient societies. Her previous work has explored the development of painted ware during the Middle and Late Neolithic periods, comparing regional differences between Thessaly and Central Greece. Effimia is particularly interested in the intersection of material culture and community identity, using ceramics as a lens through which to understand trade, social interaction, and environmental adaptation in prehistoric Greece. Her research also touches on the influence of natural disasters, such as earthquakes and tsunamis, on settlement patterns and pottery styles in coastal regions.
Publication Top Notes
“Conceptual meanings in middle Neolithic red-painted pottery from Central Greece: A case study”
“The Late Neolithic Pattern Burnished Pottery from Halai in East Locris, Central Greece: Preliminary Results of the Macroscopic Analysis”
“How did environmental factors affect the spread of Minoan Thalassocracy? Seasonal changes in winds and currents and their influence on the Minoan exchange networks”
“Painting the pots in the Middle Neolithic period. Red-on-White pottery from Central Greece”
“The development of maritime activity in the Aegean during the Bronze Age: navigational techniques and shipbuilding”
Dr.Mohammadreza Alizadeh, Iran University of Medical Sciences, Iran
Dr. Mohammadreza (Danial) Alizadeh is a highly skilled medical doctor with expertise in general and aesthetic practice. He graduated from Shahid Beheshti University of Medical Sciences, where he earned his Doctor of Medicine degree in 2020. With a passion for combining medicine and technology, Dr. Alizadeh’s diverse experiences span neurology, radiology, and health management. Currently, he serves as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co, while practicing as a General Practitioner in Mazandaran, Iran. His contributions to medical research, especially in neuroimaging, neurology, and brain injuries, reflect his commitment to advancing medical knowledge. Dr. Alizadeh is also fluent in Persian, English, and proficient in several other languages, which enhances his ability to collaborate in global settings. A passionate researcher, he has authored numerous publications in high-impact journals, particularly in neuroimaging and trauma.
Dr. Mohammadreza (Danial) Alizadeh has gained a wealth of experience across diverse medical settings. Since May 2023, he has been working as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co., Tehran, where he oversees safety protocols in a corporate environment. In parallel, he practices as a General and Aesthetic Practitioner in Amol, Mazandaran, focusing on skincare, aesthetic treatments, and general medicine. From March 2019 to February 2021, Dr. Alizadeh held the same role at Derma Hall Clinic, Tehran, performing various cosmetic procedures and consultations. His formative experience includes a two-year internship at Shahid Beheshti University of Medical Sciences, where he rotated through various medical departments, solidifying his expertise in clinical decision-making, patient care, and research. Throughout his career, he has blended patient care with research, focusing on neuroimaging and radiology, with multiple publications in renowned journals.
Awards and Honors:
Dr. Mohammadreza (Danial) Alizadeh has been recognized for his academic and professional excellence throughout his career. His notable achievements include an honor for his contribution to neuroimaging research, particularly in traumatic brain injuries, which has gained international recognition. He has received several awards for his scientific publications in peer-reviewed journals, reflecting his deep involvement in advancing medical science. Dr. Alizadeh was also awarded a distinction for his work in healthcare management during his MBA at Shahid Beheshti University of Medical Sciences, highlighting his leadership capabilities in both clinical and managerial roles. His participation in international conferences and workshops has earned him accolades from the medical community, particularly for his innovative research on neuroimaging techniques in radiology. Moreover, his expertise in aesthetic medicine has brought him local recognition, particularly for his minimally invasive cosmetic procedures.
Research Focus:
Dr. Mohammadreza (Danial) Alizadeh’s research primarily focuses on neuroimaging and its application in understanding neurological conditions and brain injuries. He is particularly interested in the diagnostic use of MRI and radiomics in the detection and progression of conditions such as glioblastoma and traumatic brain injury. His research also extends to exploring neuroinflammatory responses and imaging abnormalities associated with neurodegenerative diseases. Dr. Alizadeh is actively involved in studying the impact of aducanumab immunotherapy on amyloid-related imaging abnormalities, a groundbreaking area in Alzheimer’s treatment. His work on the role of psychiatric disorders and neuroimaging has opened new avenues for diagnosing and treating mental health conditions using cutting-edge imaging technologies. Additionally, his research on biomarkers in neurotrauma and the use of artificial intelligence in radiological interpretations reflects his forward-thinking approach to medical research.
Publications Top Notes:
🧠 “Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy”
🧪 “Clinical Decision Rules in Predicting CT Findings in Mild Traumatic Brain Injury”
🧬 “Radiomics: Differentiating Progression, Recurrence, and Radionecrosis in Gliomas”
🦠 “ALK-Positive Histiocytosis: A Deceptive Mimic of Meningioma”
🧠 “Radiomics in Psychiatric Disorders: An Emerging Diagnostic Tool”
🦠 “MRI Findings in COVID-19 Associated Encephalitis”
🧠 “Subcortical Signal Alteration of Corticospinal Tracts in ARIA”
🧠 “Serum Glial Fibrillary Acidic Protein for Intracranial Lesion Detection”
🩺 “Migraine and Subclinical Atherosclerosis: A Correlation Study”
🦠 “Effect of Underlying Diseases on COVID-19 Mortality Rate”
👶 “Choledochal Cyst in Pregnancy: A Case Report”
🧠 “Double Cystic Duct Case Report”
🧪 “Effect of Workshop vs. Lecture on Nursing and Midwifery Students”
David Monroy | Ocular Cancer | Best Researcher Award
David Monroy, University of Miami, United States
David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.
David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.
Experience :
David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.
Awards and Honors :
David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.
Research Focus :
David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.
Publication Top notes :
📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors.Expert Review of Ophthalmology, 2024.
👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series.Canadian Journal of Ophthalmology, 2024.
🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia.Eye, 2023.
💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma.Radiology Case Reports, 2022.